Applied Genetic Technologies Corporation
AGTC · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Market Cap | $35 | $128 | $117 | $67 |
| - Cash | $46 | $105 | $38 | $27 |
| + Debt | $22 | $24 | $11 | $0 |
| Enterprise Value | $11 | $48 | $89 | $40 |
| Revenue | $0 | $1 | $2 | $42 |
| % Growth | -35% | -79.6% | -94.1% | – |
| Gross Profit | $0 | $1 | $2 | $42 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$65 | -$57 | -$47 | -$4 |
| % Margin | -19,925.2% | -11,394.2% | -1,913.7% | -10.4% |
| Net Income | -$71 | -$58 | -$46 | -$2 |
| % Margin | -21,976.6% | -11,565.8% | -1,870.9% | -4.8% |
| EPS Diluted | -1.59 | -1.77 | -2.17 | -0.11 |
| % Growth | 10.2% | 18.4% | -1,872.7% | – |
| Operating Cash Flow | -$66 | -$51 | -$42 | -$23 |
| Capital Expenditures | -$2 | -$2 | -$1 | -$0 |
| Free Cash Flow | -$68 | -$53 | -$43 | -$24 |